MASIMO CORP - 01 Jul 2025 Form 4 Insider Report for Neuraxis, INC (NRXS)

Role
10%+ Owner
Signature
/s/ Micah Young, Attorney-In-Fact
Issuer symbol
NRXS
Transactions as of
01 Jul 2025
Transactions value $
-$1,847,957
Form type
4
Filing time
03 Jul 2025, 17:38:10 UTC
Previous filing
11 Aug 2023
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MASIMO CORP 10%+ Owner 52 DISCOVERY, IRVINE /s/ Micah Young, Attorney-In-Fact 03 Jul 2025 0000937556

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXS Common Stock Sale -$1.2M -532K -100% $2.25 0 01 Jul 2025 Direct
transaction NRXS Common Stock Conversion of derivative security $29.00 +290K $0.00 290K 01 Jul 2025 Direct
transaction NRXS Common Stock Sale -$652K -290K -100% $2.25 0 01 Jul 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRXS Pre-Funded Warrant, Common Stock (Right to Buy) Options Exercise $0 -290K -100% $0.00 0 01 Jul 2025 Common Stock 290K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

MASIMO CORP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The Pre-Funded Warrant (the "Warrant") is currently exercisable and has no expiration date. Upon the Issuer's consummation of an initial public offering, the Warrant automatically converted into a warrant exercisable for 289,779 shares of Issuer's Common Stock, and the exercise price was adjusted to be $0.0005 per share of the Issuer's Common Stock.